BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 15328376)

  • 1. New insights into the carrier-mediated transport of estrone-3-sulfate in the Caco-2 cell model.
    Grandvuinet AS; Gustavsson L; Steffansen B
    Mol Pharm; 2013 Sep; 10(9):3285-95. PubMed ID: 23834246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers.
    Bharadwaj R; Jaiswal S; Velarde de la Cruz EE; Thakare RP
    Diseases; 2024 Mar; 12(3):. PubMed ID: 38534987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Sodium-Dependent Organic Anion Transporter (SOAT/SLC10A6) in Physiology and Pathophysiology.
    Wannowius M; Karakus E; Aktürk Z; Breuer J; Geyer J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jadomycins: A potential chemotherapy for multi-drug resistant metastatic breast cancer.
    Bonitto EP; McKeown BT; Goralski KB
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00886. PubMed ID: 34708587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis.
    Tang T; Wang G; Liu S; Zhang Z; Liu C; Li F; Liu X; Meng L; Yang H; Li C; Sang M; Zhao L
    Sci Rep; 2021 Jan; 11(1):631. PubMed ID: 33436824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis.
    Sutherland R; Meeson A; Lowes S
    Cancer Metastasis Rev; 2020 Sep; 39(3):919-932. PubMed ID: 32388639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen.
    Windt T; Tóth S; Patik I; Sessler J; Kucsma N; Szepesi Á; Zdrazil B; Özvegy-Laczka C; Szakács G
    Arch Toxicol; 2019 Apr; 93(4):953-964. PubMed ID: 30863990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology.
    Schulte RR; Ho RH
    Mol Pharmacol; 2019 May; 95(5):490-506. PubMed ID: 30782852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6).
    Karakus E; Zahner D; Grosser G; Leidolf R; Gundogdu C; Sánchez-Guijo A; Wudy SA; Geyer J
    Front Pharmacol; 2018; 9():941. PubMed ID: 30186172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.
    Dudenkov TM; Ingle JN; Buzdar AU; Robson ME; Kubo M; Ibrahim-Zada I; Batzler A; Jenkins GD; Pietrzak TL; Carlson EE; Barman P; Goetz MP; Northfelt DW; Moreno-Aspita A; Williard CV; Kalari KR; Nakamura Y; Wang L; Weinshilboum RM
    Breast Cancer Res Treat; 2017 Jul; 164(1):189-199. PubMed ID: 28429243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance.
    Lee HH; Leake BF; Kim RB; Ho RH
    Mol Pharmacol; 2017 Jan; 91(1):14-24. PubMed ID: 27777271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Regulation of Steroid Action by Sulfation and Desulfation.
    Mueller JW; Gilligan LC; Idkowiak J; Arlt W; Foster PA
    Endocr Rev; 2015 Oct; 36(5):526-63. PubMed ID: 26213785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic anion transporting polypeptides expressed in pancreatic cancer may serve as potential diagnostic markers and therapeutic targets for early stage adenocarcinomas.
    Hays A; Apte U; Hagenbuch B
    Pharm Res; 2013 Sep; 30(9):2260-9. PubMed ID: 23307416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and function of organic anion transporting polypeptides in normal tissues and in cancer.
    Obaidat A; Roth M; Hagenbuch B
    Annu Rev Pharmacol Toxicol; 2012; 52():135-51. PubMed ID: 21854228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.
    Lee W; Belkhiri A; Lockhart AC; Merchant N; Glaeser H; Harris EI; Washington MK; Brunt EM; Zaika A; Kim RB; El-Rifai W
    Cancer Res; 2008 Dec; 68(24):10315-23. PubMed ID: 19074900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer.
    Meyer zu Schwabedissen HE; Tirona RG; Yip CS; Ho RH; Kim RB
    Cancer Res; 2008 Nov; 68(22):9338-47. PubMed ID: 19010908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin administration and high-fat diet on the body weight and hepatic estrogen metabolism in female C3H/HeN mice.
    Zhu BT; Gallo MA; Burger CW; Meeker RJ; Cai MX; Xu S; Conney AH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):107-18. PubMed ID: 17945325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of cell proliferation by inhibition of estrone-3-sulfate transporter in estrogen-dependent breast cancer cells.
    Nozawa T; Suzuki M; Yabuuchi H; Irokawa M; Tsuji A; Tamai I
    Pharm Res; 2005 Oct; 22(10):1634-41. PubMed ID: 16180120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells.
    Nozawa T; Suzuki M; Takahashi K; Yabuuchi H; Maeda T; Tsuji A; Tamai I
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1032-7. PubMed ID: 15328376
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.